MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • ND0701: A new concentrated formulation of Apomorphine for continuous subcutaneous administration – human PK data

    L. Adar, C. Durlach, O. Yacoby Zeevi, D. Fishelovitch, S. Oren (Rehovot, Israel)

  • Network for parallel gamma synchronizations during upper limb movement

    G. Tamas, A. Anwar, G. Deuschl, J. Raethjen, S. Groppa, M. Muthuraman (Budapest, Hungary)

  • Neural correlates of minor hallucinations in Parkinson’s disease: A multimodal imaging study

    H. Bejr-kasem, J. Pagonabarraga, S. Martinez-Horta, F. Sampedro, J. Marin-Lahoz, J. Perez-Perez, A. Horta-Barba, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

  • Neural correlates of movement sequence kinematics in substantia nigra dopaminergic cells

    M. Mendonça, J. Alves Silva, L. Hernandez, J. Obeso, R. Costa (Lisboa, Portugal)

  • Neural Correlates Underlying Reward Processing and Decision-Making in Impulse Control Disorder in Parkinson´s Disease

    I. Navalpotro-Gomez, P. Paz-Alonso, P. Boddy, M. Delgado-Alvarado, H. Jimenez-Urbieta, A. Quiroga-Varela, B. Gago, M. Carreiras, M.C. Rodriguez-Oroz (San Sebastian, Spain)

  • Neuroactive steroids reverse the dopaminergic neurotransmission defectiveness in chronic hepatic (HE) encephalopathy: a possible involvement in HE related parkinsonism

    O. El Hiba, A. EL Khiat, H. Gamrani (EL Jadida, Morocco)

  • Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients

    S.J. Kim (Busan, Republic of Korea)

  • Neurodegenerative biomarker abnormality frequency in idiopathic REM sleep behavior disorder

    A. Boeve, S. McCord, P. Timm, D. Sandness, N. Commers, E. Duwell, G. Tabatabai, S. McCarter, M. Junna, M. Lipford, M. Tippmann-Peikert, B. Boeve, M. Silber, E. St. Louis (Rochester, MN, USA)

  • Neuroferritinopathy pedigree in 2 families from India

    J. Kaur, G. Singh, B. Paul (Ludhiana, India)

  • Neurofilament light chain levels in cerebrospinal fluid do not discriminate between patients with prion disease and mimics

    B. Roeben, E. Stransky, K. Brockmann, R. Schüle, W. Maetzler, T. Gasser, G. Machetanz (Tübingen, Germany)

  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley